Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Violin Jonathan, Director. Director active across 2 companies, notably Astria Therapeutics, Inc.. Cumulatively, 10 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €3.4m. Activity tracked since 20 September 2021. The latest transaction was filed on 2 February 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Violin Jonathan is Président et Administrateur. He is linked to Viridian Therapeutics, Inc.\DE, where he is Chief Executive Officer, and to Astria Therapeutics, Inc., where he is Director. Across the 10 filings recorded, the 10 observed filings between 2021-09-22 and 2026-01-23 are all sales, with sum_sell_eur of 3429479 and sum_buy_eur of 0.